![]() CalciMedica CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors. | ![]() Palatin Technologies Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases. | ![]() Acticor Biotech Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. | ![]() Albumedix Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases. | |
Founding Date | Founding Date 2007 | Founding Date 1986 | Founding Date 2013 | Founding Date 2016 |
Type | Type Public | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations La Jolla, US HQ | Locations East Windsor, US HQ | Locations Paris, FR HQ Paris, FR | Locations Nottinghamshire, GB HQ Nottingham, GB |
Employees | Employees 1614% increase | Employees 185% decrease | Employees 1711% decrease | Employees 871% increase |
Valuation ($) | Valuation ($) 42.4 m | Valuation ($) 22.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($29.6m) (FY, 2025) | Net income ($17.3m) (FY, 2025) | Net income N/A | Net income £5m (FY, 2018) |
Funding | ||||
Total funding raised | Total funding raised $ 74.5m | Total funding raised $ 104.2m | Total funding raised $ 33.3m | Total funding raised N/A |

Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
View company
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
View company
Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases.
View company